EHA 2019: Dr. John Pagel on New Ways to BTK (Block Bruton’s Tyrosine) Kinase in CLL (chronic lymphocytic leukemia) In this video, Dr. Brian Koffman, M.D. a CLL patient, family physician and Chief Medical Officer of the CLL Society,... November 18, 20192019 ConferencesBy Brad Hedrick
EHA 2019: Dr. Susan O’Brien on Frontline Therapy in CLL Dr. Susan O’Brien moved from MD Anderson to head up the CLL research and clinical team at the University of... November 18, 20192019 Conferences, TreatmentBy Brad Hedrick
EHA 2019: Dr. Paolo Ghia MD PhD on Phase 3 Trial for Relapsed or Refractory CLL (chronic lymphocytic leukemia) At EHA (European Hematology Association) Annual Congress, 2019 in Amsterdam, I spoke with Dr. Paolo Ghia who is president of... November 12, 20192019 ConferencesBy Brad Hedrick
EHA 2019: Dr. Peter Hillman on Venetoclax and Obinutuzumab in CLL (chronic lymphocytic leukemia) In my interview with Dr. Peter Hillmen of Leeds, UK at EHA, the European Hematology Association Annual Congress, held in... November 12, 20192019 ConferencesBy Brad Hedrick
EHA 2019: Dr. Matthew Davids On Richter’s Transformation in CLL (chronic lymphocytic leukemia) Great progress has been made in treating chronic lymphocytic leukemia, but sadly the outcomes for Richter’s Transformation (RT)) or Richter’s... November 4, 20192019 ConferencesBy Brad Hedrick
EHA 2019: Dr. Peter Hillmen on Watch and Wait versus early Ibrutinib in CLL (chronic lymphocytic leukemia) Watch and wait is one of the most counter-intuitive and anxiety provoking time for CLL patients, so studying the question... November 4, 20192019 ConferencesBy Brad Hedrick
EHA 2019, Amsterdam: Dr. Alexey Danilov on the SYK Inhibitor, Entospletinib + Obinutuzumab in Relapsed/Refractory CLL (chronic lymphocytic leukemia) At the 24th European Hematology Association Annual Congress in Amsterdam, Holland held in 2019, I interviewed Dr. Alexey Danilov of... November 4, 20192019 ConferencesBy Brad Hedrick
ERIC 2018, Barcelona: Dr. Aliki Xochelli on the Doctor/Patient Relationship in CLL (chronic lymphocytic leukemia) From ERIC, Dr. John Seymour talks about Monoclonal B-cell Lymphocytosis (MBL), a precursor of CLL.... October 27, 20192018 ConferencesBy Brad Hedrick
E.R.I.C. Barcelona 2018: Professor John Seymour on MBL or Monoclonal B-cell Lymphocytosis, a CLL (chronic lymphocytic leukemia) From ERIC, Dr. John Seymour talks about Monoclonal B-cell Lymphocytosis (MBL), a precursor of CLL.... October 27, 20192018 ConferencesBy Brad Hedrick
ERIC 2018: Paolo Ghia MD PhD on Standardizing Testing P53 and Other Testing in CLL (chronic lymphocytic leukemia) Dr. Ghia is a CLL researcher in Milano and president of ERIC (European Research Initiative on CLL) talks about the... October 21, 20192018 ConferencesBy Brad Hedrick
